ARVS from June 23 – 25, 2017 in Ottawa Canada
BioStable Science & Engineering will be at the Aortic Valve Repair Summit (ARVS) from June 23 - 25, 2017 in Ottawa, Canada.
First Commercial Use of the HAART 300 in US
BioStable Science & Engineering Announces announced today the first commercial uses of the HAART 300 Aortic Annuloplasty Device in the U.S. by doctors at the West Virginia University (WVU) Heart and Vascular Institute in Morgantown, West Virginia. Dr. Lawrence Wei, Dr. Vinay Badhwar and Dr. J. Scott Rankin, were the collaborating surgeons for the procedures.
Boston, MA – April 29 – May 3, 2017 – AATS Centennial
BioStable Science & Engineering will be at the 100th Anniversary of the American Association for Thoracic Surgery - AATS Centennial - from April 29 - May 3, 2017 in Boston, MA - booth 834.
HAART 300 Receives FDA Clearance
BioStable Science & Engineering, Inc. announced today it has received FDA market clearance for the HAART 300 Aortic Annuloplasty Device, the first commercially available internal annuloplasty device designed for aortic valve repair.
Leipzig, Germany – Feb 11-14, 2017 – Heart Medicine 2017
BioStable Science & Engineering will be at the 46th Annual Meeting of the German Society for Thoracic, Cardiac and Vascular Surgery - Heart Medicine 2017 from February 11 - 14, 2017 in Leipzig, Germany - booth C.11.